Question special
Faculty Member

Based on the data on adverse events in Table 2 and Table S4, 81% had respiratory symptoms including 23% with throat tightness, and 85% had GI symptoms including 40-50% with vomiting and abdominal pain, however, epinephrine was administered in only 14% of the active drug group.

Was the majority of these described symptoms occurring later after the dose and thought to be due to intercurrent illnesses not from the treatment? Or other explanations?